Ocrelizumab-Induced Severe Colitis
We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. Histology of the colectomy was consistent with medication-induced colitis.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Gastrointestinal Medicine |
| Online Access: | http://dx.doi.org/10.1155/2020/8858378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560229654462464 |
|---|---|
| author | Hsing Hwa Lee Naveen Sritharan Daniel Bermingham Gabriela Strey |
| author_facet | Hsing Hwa Lee Naveen Sritharan Daniel Bermingham Gabriela Strey |
| author_sort | Hsing Hwa Lee |
| collection | DOAJ |
| description | We report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. Histology of the colectomy was consistent with medication-induced colitis. |
| format | Article |
| id | doaj-art-1e8178303b9d461ba2e1816a10d3f081 |
| institution | Kabale University |
| issn | 2090-6528 2090-6536 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Gastrointestinal Medicine |
| spelling | doaj-art-1e8178303b9d461ba2e1816a10d3f0812025-02-03T01:28:08ZengWileyCase Reports in Gastrointestinal Medicine2090-65282090-65362020-01-01202010.1155/2020/88583788858378Ocrelizumab-Induced Severe ColitisHsing Hwa Lee0Naveen Sritharan1Daniel Bermingham2Gabriela Strey3Department of Medicine, Hervey Bay Hospital, Pialba, Queensland, AustraliaDepartment of Medicine, Hervey Bay Hospital, Pialba, Queensland, AustraliaDepartment of Pharmacy, Hervey Bay Hospital, Pialba, Queensland, AustraliaDepartment of Medicine, Hervey Bay Hospital, Pialba, Queensland, AustraliaWe report a case of severe ocrelizumab (anti-CD20 monoclonal antibody) induced colitis in a 43-year-old woman with multiple sclerosis leading to total colectomy after failing medical therapy. Histology of the colectomy was consistent with medication-induced colitis.http://dx.doi.org/10.1155/2020/8858378 |
| spellingShingle | Hsing Hwa Lee Naveen Sritharan Daniel Bermingham Gabriela Strey Ocrelizumab-Induced Severe Colitis Case Reports in Gastrointestinal Medicine |
| title | Ocrelizumab-Induced Severe Colitis |
| title_full | Ocrelizumab-Induced Severe Colitis |
| title_fullStr | Ocrelizumab-Induced Severe Colitis |
| title_full_unstemmed | Ocrelizumab-Induced Severe Colitis |
| title_short | Ocrelizumab-Induced Severe Colitis |
| title_sort | ocrelizumab induced severe colitis |
| url | http://dx.doi.org/10.1155/2020/8858378 |
| work_keys_str_mv | AT hsinghwalee ocrelizumabinducedseverecolitis AT naveensritharan ocrelizumabinducedseverecolitis AT danielbermingham ocrelizumabinducedseverecolitis AT gabrielastrey ocrelizumabinducedseverecolitis |